Comments on: Live from DC – It’s the FDA Open Forum on Internet and Social Media

By: Pharma: Ask Not What Social Media Can Do For You, But What Your SM Can Do For Patient Health | AdvanceMarketWoRx

Mon, 27 Jun 2011 22:45:12 +0000

[...] are also many terrific blogs and summaries on the 2-day FDA Advisory Meeting: Shwen’s Live from DC extensive list of #fdasm blogs, Pixels & Pills EXCLUSIVE Interview with Thomas Abrams at the [...]

By: Med 2.0 » Blog Archive » FDA Delays Social Media Guidelines Till Q1 2011

Tue, 21 Dec 2010 14:13:36 +0000

[...] may recall that this all started with the FDA Open Forum to address Internet and Social Media guidance in NOV 2009. Over the course of the year since then, general chatter and bits of [...]

By: Building a brand using social media | Pharma Strategy Blog

Building a brand using social media | Pharma Strategy Blog — Tue, 26 Oct 2010 23:31:25 +0000

[...] Twitter buddy, Shwen Gwee, posted about the hearing and pointed to the links to the presentations, so if you're in the Pharma and Biotech industry and reading this blog or know of friends who [...]

By: Why Guidance Will Not be the Most Important Thing to Come Out of the FDA Social Media Hearings | PRforPharma

Mon, 16 Nov 2009 21:45:50 +0000

[...] in a presentation has been examined ad nauseam (for a list of recaps on the event, take a look at Shwen Gwee’s post). For two days last week, social media took center stage in the pharmaceutical marketing mix. [...]

By: shwen

shwen — Mon, 16 Nov 2009 20:03:15 +0000

EARL: Thanks so much for your comment and compliment. Glad to be a useful resource – I figured that I would want to aggregate the various resources for my own reference anyway, so rather than add more comments/review of the hearing, it seemed better to just aggregate them all. I’ll post my personal take some time soon. BTW, congrats again on the launch of AZHC once again. One step at a time…

By: Earl Whipple

Earl Whipple — Mon, 16 Nov 2009 19:55:16 +0000

Shwen, my compliments on your comprehensive coverage of the FDA hearings. Frankly there are so many opinions it is taking me some time to digest. Your approach is helpful in breaking donw the information into understandable bytes.